Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 258
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots Phase 3
Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate
Review: Colorado Psychedelic Cup 2025
Dr Ros Watts – Building Communities and Connection
The Psychedelic News Feed: October 27 – November 02, 2025
Psychedelic Bulletin: MindMed Uplists to Nasdaq; Cybin Targets Alcoholism; COMPASS Announces...
Ketanserin’s Contributions to Psychedelic Research
Should Society Legalize Psychedelics? A Breakdown of the Intelligence Squared Debate
PTSF57 – New Compounds, Psychedelic Business, and Neurogenesis
COMPASS Pathways announces pricing of public offering
Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace...
Op-Ed: Re-evaluating the Results of the Recent Trial of Psilocybin vs...
Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation
Tryp Therapeutics Announces Q2 2021 Financial Results
Small Pharma Completes Reverse Take-Over Transaction
1
...
257
258
259
...
301
Page 258 of 301
